US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ASTRAZENECA PLC ADRhedged

53.28

0.0000

Volume:- -

Turnover:- -

Market Cap:1.60M

PE:- -

High:53.28

Open:53.28

Low:53.28

Close:53.28

52wk High:56.90

52wk Low:44.36

Shares:30.00K

Float Shares:10.00K

Volume Ratio:2.68

T/O Rate:- -

Dividend:0.58

Dividend Rate:1.08%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

AstraZeneca PLC Stock Falls Friday, Underperforms Market

Jefferies sees neutral to negative read-through to Alnylam from AstraZeneca data

AstraZeneca Targets Pediatric Asthma Gains With New Glycopyrronium Trial

AstraZeneca Advances Off‑the‑Shelf CAR‑T Program in Tough‑to‑Treat Multiple Myeloma

Amgen, AstraZeneca announce Crossing trial showed ‘meaningful’ improvements

Amgen, AstraZeneca report CROSSING trial met co-primary and secondary endpoints

AstraZeneca, Amgen Phase 3 Trial Shows Tezspire Eases Swallowing Difficulties for EoE Patients

MT Newswires Live

AstraZeneca's Tezspire Meets Esophagitis Late-Stage Trial Goals

AstraZeneca Slides Wednesday, Underperforms Market

AstraZeneca Deepens Its Type 2 Diabetes Pipeline With New Global Patient Mapping Study

AstraZeneca Climbs Tuesday, Outperforms Market

AstraZeneca (AZN) Receives a Sell from Deutsche Bank

Astrazeneca Prices $2.97 Billion Eurobond Offering

MT Newswires Live

AstraZeneca’s AZD4144 Interaction Study Adds Quiet Support to AZN’s Pipeline Story

AstraZeneca Rallies Friday, Outperforms Market

AstraZeneca’s SELENE 3 Trial Targets Extra Weight-Loss Upside for AZN Investors

Dizhe Pharma Surpasses 500 Million Yuan in First-Half Revenue, Seals Global Exclusive Licensing Pact with AstraZeneca for Sunvozertinib

Third Indication Approved in China for AstraZeneca's Ultomiris

AstraZeneca PLC Stock (AZN) Moved Up by 3.40% on Aug 19: What Signal Does It Send?

The Key to Pharma M&A: Never Shopping Hungry - Heard on the Street

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/AZNH/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AZNH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AZNH\",,,,,undefined,":{"symbol":"AZNH","market":"US","secType":"STK","nameCN":"ASTRAZENECA PLC ADRhedged","latestPrice":53.2774,"timestamp":1787947200000,"preClose":53.2774,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":10000,"shares":30000,"eps":0,"marketStatus":"Halted","change":0,"latestTime":"08-28 16:00:00 EDT","open":53.2774,"high":53.2774,"low":53.2774,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788163200000},"marketStatusCode":7,"adr":0,"exchange":"NYSE","adjPreClose":53.2774,"dividendRate":0.010836,"bidAskSpread":0,"volumeRatio":2.6812474453400963},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AZNH\",,,,,undefined,":{"symbol":"AZNH","floatShares":10000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.6812474453400963,"shares":30000,"dividePrice":0.57729,"high":53.2774,"amplitude":0,"preClose":53.2774,"low":53.2774,"week52Low":44.36,"pbRate":"--","week52High":56.8955,"institutionHeld":0,"latestPrice":53.2774,"eps":0,"divideRate":0.010836,"volume":0,"delay":0,"ttmEps":0,"open":53.2774,"prevYearClose":54.226,"prevWeekClose":53.2774,"prevMonthClose":53.2774,"prevQuarterClose":53.2774,"fiveDayClose":53.2774,"twentyDayClose":53.2774,"sixtyDayClose":53.2774},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AZNH\",params:#limit:5,,,undefined,":[{"date":"2025-12-16","symbol":"AZNH","amount":0.57729,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"ASTRAZENECA PLC ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"},{"date":"2024-12-16","symbol":"AZNH","amount":2.71402,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-16","defaultRemindTime":1734359400000,"name":"ASTRAZENECA PLC ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-23","payableDate":"2024-12-16","currency":"USD","dateTimestamp":1734325200000,"payDate":"2024-12-23"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AZNH\",market:\"US\",,,undefined,":[{"executeDate":"2024-12-16","recordDate":"2024-12-16","paymentDate":"2024-12-23","value":2.71402,"currency":"USD"},{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.57729,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AZNH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AZNH\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2663920590","title":"AstraZeneca PLC Stock Falls Friday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2663920590","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663920590?lang=en_us&edition=fundamental","pubTime":"2026-08-29 00:00","pubTimestamp":1787932800,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of AstraZeneca PLC shed 0.8% to SEK1,559.00 Friday on what proved to be an overall favorable trading session for the stock market, with the OMX Nordic 40 Index rising 0.1% to 2,733.09.This was the stock's third consecutive day of losses.The company closed SEK366.50 short of its 52-week high of SEK1,925.50, which the company achieved on April 10, 2026.Trading volume was 377,982, compared to the 50-day average trading volume of 543,948.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0708994859.HKD","LU2237443465.HKD","LU0432979614.USD","IE00B3T34201.USD","LU2237443978.SGD","LU0889565916.HKD","LU0310800379.SGD","LU0128525929.USD","LU0109394709.USD","LU0289739699.SGD","BK4007","LU1267930573.SGD","LU2236285917.USD","BK4568","LU2089984988.USD","LU2237443622.USD","LU0058720904.USD","AZNH","LU2417539215.USD","LU2237443549.SGD","LU0320765992.SGD","LU2237443382.USD","LU2468319806.SGD","BK4585","LU2456880835.USD","LU2237443895.HKD","LU2462157665.USD","LU1829250122.USD","AZN","BK4588","LU0029864427.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662093221","title":"Jefferies sees neutral to negative read-through to Alnylam from AstraZeneca data","url":"https://stock-news.laohu8.com/highlight/detail?id=2662093221","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662093221?lang=en_us&edition=fundamental","pubTime":"2026-08-28 20:50","pubTimestamp":1787921420,"startTime":"0","endTime":"0","summary":"After Ionis Pharmaceuticals (IONS) and AstraZeneca (AZN) presented full results of the Cardio-TTRansform trial at the ESC Congress 2026 in Munich, ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jefferies-sees-neutral-to-negative-read-through-to-alnylam-from-astrazeneca-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jefferies-sees-neutral-to-negative-read-through-to-alnylam-from-astrazeneca-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128525929.USD","LU2462157665.USD","LU0310800379.SGD","LU0289739699.SGD","BK4585","LU0889565916.HKD","LU0058720904.USD","LU0432979614.USD","LU1267930573.SGD","LU2456880835.USD","LU1829250122.USD","LU2468319806.SGD","LU0708994859.HKD","IONS","LU0109394709.USD","LU2417539215.USD","LU2237443978.SGD","BK4007","AZN","LU2236285917.USD","LU0029864427.USD","LU2237443895.HKD","LU2237443382.USD","LU2237443465.HKD","LU2237443549.SGD","LU2237443622.USD","AZNH","BK4588","LU2089984988.USD","BK4568","LU0320765992.SGD","BK4139","IE00B3T34201.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662084908","title":"AstraZeneca Targets Pediatric Asthma Gains With New Glycopyrronium Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2662084908","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662084908?lang=en_us&edition=fundamental","pubTime":"2026-08-28 00:31","pubTimestamp":1787848302,"startTime":"0","endTime":"0","summary":"AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. AstraZeneca plc (AZN) is running a Phase II trial called “A Phase II...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/astrazeneca-targets-pediatric-asthma-gains-with-new-glycopyrronium-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/astrazeneca-targets-pediatric-asthma-gains-with-new-glycopyrronium-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","AZN","LU2462157665.USD","LU0310800379.SGD","LU0432979614.USD","BK4585","LU2237443622.USD","LU2089984988.USD","BK4568","LU2456880835.USD","BK4007","LU2237443978.SGD","LU2237443895.HKD","LU0289739699.SGD","LU2417539215.USD","LU2237443549.SGD","IE00B3T34201.USD","LU0320765992.SGD","LU0708994859.HKD","LU0128525929.USD","LU2468319806.SGD","AZNH","LU2237443382.USD","LU1829250122.USD","LU2236285917.USD","BK4588","LU0029864427.USD","LU1267930573.SGD","LU0058720904.USD","LU2237443465.HKD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662995084","title":"AstraZeneca Advances Off‑the‑Shelf CAR‑T Program in Tough‑to‑Treat Multiple Myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=2662995084","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662995084?lang=en_us&edition=fundamental","pubTime":"2026-08-28 00:31","pubTimestamp":1787848284,"startTime":"0","endTime":"0","summary":"AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. AstraZeneca (AZN) is advancing a new study of AZD4045 in adults with...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/astrazeneca-advances-offtheshelf-cart-program-in-toughtotreat-multiple-myeloma?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/astrazeneca-advances-offtheshelf-cart-program-in-toughtotreat-multiple-myeloma?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0708994859.HKD","LU2456880835.USD","BK4007","AZN","LU2237443382.USD","LU0432979614.USD","IE00B3T34201.USD","LU1267930573.SGD","LU0109394709.USD","LU0889565916.HKD","BK4588","LU2236285917.USD","BK4568","LU2237443622.USD","LU0029864427.USD","LU2237443549.SGD","LU2089984988.USD","LU2237443465.HKD","LU1829250122.USD","LU2417539215.USD","BK4585","LU2237443978.SGD","LU2237443895.HKD","LU0320765992.SGD","LU0058720904.USD","AZNH","LU0289739699.SGD","LU2462157665.USD","LU0310800379.SGD","LU0128525929.USD","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662013447","title":"Amgen, AstraZeneca announce Crossing trial showed ‘meaningful’ improvements","url":"https://stock-news.laohu8.com/highlight/detail?id=2662013447","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662013447?lang=en_us&edition=fundamental","pubTime":"2026-08-27 19:15","pubTimestamp":1787829352,"startTime":"0","endTime":"0","summary":"Positive high-level results from the Phase III CROSSING trial in patients with eosinophilic esophagitis showed that AstraZeneca (AZN) and Amgen’s (...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amgen-astrazeneca-announce-crossing-trial-showed-meaningful-improvements-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amgen-astrazeneca-announce-crossing-trial-showed-meaningful-improvements-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","PJP","TBXU","BBH","BK4568","LU0128525929.USD","LU1023059063.AUD","IBB","IE00B3T34201.USD","LU2237443978.SGD","LU2462157665.USD","IE00B4R5TH58.HKD","LU2468319806.SGD","LU2417539215.USD","LU1267930573.SGD","AZN","IBBQ","LU2242652126.USD","LU0289739699.SGD","BK4566","LU0868494617.USD","LU2236285917.USD","LU2456880835.USD","BK4139","LU2242646821.SGD","PBE","LU2237443622.USD","AMGN","LU0122379950.USD","LU0708994859.HKD","IE00BFTCPJ56.SGD","LU2089984988.USD","IE0009355771.USD","IE0002141913.USD","LU2237443465.HKD","LU1829250122.USD","IE00BJJMRZ35.SGD","LU0029864427.USD","BK4534","BK4533","AZNH","IE00B2B36J28.USD","LU2237443382.USD","LU0432979614.USD","IE00BJT1NW94.SGD","BK4581","LU1057294990.SGD","BIB","BK4007","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662877754","title":"Amgen, AstraZeneca report CROSSING trial met co-primary and secondary endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2662877754","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662877754?lang=en_us&edition=fundamental","pubTime":"2026-08-27 17:15","pubTimestamp":1787822113,"startTime":"0","endTime":"0","summary":"Amgen (AMGN) and AstraZeneca (AZN) announced top-line results from the Phase 3 CROSSING trial of Tezspire in patients living with eosinophilic esop...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amgen-astrazeneca-report-crossing-trial-met-co-primary-and-secondary-endpoints-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amgen-astrazeneca-report-crossing-trial-met-co-primary-and-secondary-endpoints-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2112291526.USD","LU0058720904.USD","BK4568","AZNH","IE0002141913.USD","BK4588","AMGN","IE00BJT1NW94.SGD","LU1267930573.SGD","BK4007","LU0128525929.USD","LU2468319806.SGD","PBE","LU0889565916.HKD","PJP","LU0122379950.USD","TBXU","IE00BJJMRZ35.SGD","IBB","LU0320765992.SGD","LU1061106388.HKD","LU1571399168.USD","LU2417539215.USD","BK4533","BK4581","BK4599","AZN","IBBQ","IE00B2B36J28.USD","LU2237443895.HKD","LU1829250122.USD","BK4585","LU1057294990.SGD","LU2236285917.USD","LU2237443465.HKD","LU2237443978.SGD","IE0009355771.USD","LU1983299246.USD","BK4566","BIB","LU1023059063.AUD","IE00B3T34201.USD","BBH","LU0029864427.USD","LU2456880835.USD","LU0289739699.SGD","IE00BFTCPJ56.SGD","LU0432979614.USD","LU2242646821.SGD","LU0868494617.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662771175","title":"AstraZeneca, Amgen Phase 3 Trial Shows Tezspire Eases Swallowing Difficulties for EoE Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2662771175","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662771175?lang=en_us&edition=fundamental","pubTime":"2026-08-27 16:24","pubTimestamp":1787819085,"startTime":"0","endTime":"0","summary":"AstraZeneca  and Amgen  said Thursday their drug Tezspire met the primary endpoints of a Phase 3 trial treating eosinophilic esophagitis, a chronic inflammatory esophagus disorder.The medication met both primary endpoints by reducing tissue inflammation and easing swallowing difficulties at week 24 compared to a placebo, the companies said.The disease and symptom improvements were maintained through week 52 for both tested doses, they said.The companies also said the safety profile of the treatment during the study remained consistent with its previously approved uses.Shares of Amgen were down by over 1% in Thursday premarket activity.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2112291526.USD","LU0058720904.USD","IE00B4R5TH58.HKD","AZNH","LU2462157665.USD","IE00BJT1NW94.SGD","AMGN","LU1267930573.SGD","BK4007","LU0128525929.USD","LU0109394709.USD","LU2242652126.USD","LU2089984988.USD","PBE","LU0889565916.HKD","PJP","TBXU","LU2237443622.USD","LU0708994859.HKD","IE00BJJMRZ35.SGD","IBB","LU1061106388.HKD","LU1571399168.USD","BK4533","BK4581","BK4599","AZN","IBBQ","IE00B2B36J28.USD","LU2237443895.HKD","BK4534","LU0310800379.SGD","LU1829250122.USD","BK4585","LU1057294990.SGD","LU2237443465.HKD","LU2237443549.SGD","LU2237443978.SGD","LU1983299246.USD","BK4566","BIB","BBH","LU0029864427.USD","LU2456880835.USD","LU2237443382.USD","LU0289739699.SGD","IE00BFTCPJ56.SGD","LU0432979614.USD","LU2242646821.SGD","LU0868494617.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662101775","title":"AstraZeneca's Tezspire Meets Esophagitis Late-Stage Trial Goals","url":"https://stock-news.laohu8.com/highlight/detail?id=2662101775","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662101775?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:52","pubTimestamp":1787813520,"startTime":"0","endTime":"0","summary":"AstraZeneca reported positive results from its Phase 3 trial of Tezspire in patients with eosinophilic esophagitis, an inflammatory disorder of the esophagus.The Cambridge-based pharmaceutical company said Thursday that the drug demonstrated improvements across co-primary and all key secondary endpoints at week 24 of the trial, which were sustained to week 52.The co-primary endpoints were histologic remission and the frequency and severity of dysphagia--or difficulty swallowing--compared with the placebo. The safety profile of the drug was generally consistent with its approved indications, AstraZeneca added.The drug is being developed in collaboration with U.S. biotechnology company Amgen.Tezspire is currently approved for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps in the U.S., EU, China and Japan.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2462157665.USD","BK4585","AZN","LU2237443895.HKD","LU0109394709.USD","LU2237443978.SGD","BK4568","LU2417539215.USD","LU2468319806.SGD","LU0708994859.HKD","LU2456880835.USD","LU1267930573.SGD","AZNH","IE00B3T34201.USD","LU0889565916.HKD","LU0432979614.USD","LU0029864427.USD","BK4588","LU2237443382.USD","LU2237443465.HKD","LU2237443622.USD","LU2236285917.USD","LU0058720904.USD","LU2089984988.USD","LU0289739699.SGD","LU0128525929.USD","LU0320765992.SGD","LU2237443549.SGD","LU1829250122.USD","LU0310800379.SGD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662745884","title":"AstraZeneca Slides Wednesday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2662745884","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662745884?lang=en_us&edition=fundamental","pubTime":"2026-08-27 00:06","pubTimestamp":1787760360,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of AstraZeneca PLC  slid 1.94% to GBP122.34 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the FTSE 100 Index  falling 0.07% to 10,878.12.AstraZeneca PLC closed 22.23% short of its 52-week high of GBP157.32, which the company reached on February 18th.Trading volume totaled 2.0 million, compared to the 50-day average of 3.3 million.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443549.SGD","LU0128525929.USD","LU2468319806.SGD","LU0432979614.USD","AZNH","LU2237443895.HKD","LU0109394709.USD","LU2236285917.USD","LU1267930573.SGD","LU2237443622.USD","LU2417539215.USD","LU2089984988.USD","LU2462157665.USD","LU2237443382.USD","LU2456880835.USD","LU2237443978.SGD","LU0320765992.SGD","LU2237443465.HKD","LU0058720904.USD","LU0310800379.SGD","LU0889565916.HKD","BK4568","BK4588","IE00B3T34201.USD","BK4585","BK4007","AZN","LU0708994859.HKD","LU0029864427.USD","LU0289739699.SGD","LU1829250122.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662759855","title":"AstraZeneca Deepens Its Type 2 Diabetes Pipeline With New Global Patient Mapping Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2662759855","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662759855?lang=en_us&edition=fundamental","pubTime":"2026-08-26 00:30","pubTimestamp":1787675440,"startTime":"0","endTime":"0","summary":"AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. AstraZeneca plc (AZN) is running an observational study titled “A St...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/astrazeneca-deepens-its-type-2-diabetes-pipeline-with-new-global-patient-mapping-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/astrazeneca-deepens-its-type-2-diabetes-pipeline-with-new-global-patient-mapping-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LU0889565916.HKD","LU2417539215.USD","LU0109394709.USD","LU2456880835.USD","LU2462157665.USD","LU2237443465.HKD","LU1267930573.SGD","AZN","LU0310800379.SGD","LU2236285917.USD","LU2237443622.USD","LU0320765992.SGD","LU0128525929.USD","BK4585","BK4588","LU0289739699.SGD","LU0708994859.HKD","LU2468319806.SGD","BK4568","LU1829250122.USD","LU2237443549.SGD","LU2237443978.SGD","LU2237443382.USD","LU2237443895.HKD","LU0058720904.USD","IE00B3T34201.USD","LU0432979614.USD","LU0029864427.USD","LU2089984988.USD","AZNH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662756389","title":"AstraZeneca Climbs Tuesday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2662756389","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662756389?lang=en_us&edition=fundamental","pubTime":"2026-08-26 00:05","pubTimestamp":1787673900,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of AstraZeneca PLC  rallied 3.02% to GBP124.76 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index  rising 0.29% to 10,886.16.AstraZeneca PLC closed 20.70% short of its 52-week high of GBP157.32, which the company achieved on February 18th.Trading volume totaled 1.4 million, compared to the 50-day average of 3.3 million.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1267930573.SGD","LU2089984988.USD","LU2237443895.HKD","BK4568","LU0289739699.SGD","BK4588","LU2468319806.SGD","LU0889565916.HKD","LU2462157665.USD","BK4007","LU0432979614.USD","LU2237443978.SGD","LU2237443622.USD","LU0128525929.USD","LU2417539215.USD","LU2456880835.USD","LU0109394709.USD","IE00B3T34201.USD","LU0029864427.USD","LU2237443465.HKD","LU0708994859.HKD","LU0058720904.USD","LU0320765992.SGD","LU0310800379.SGD","BK4585","LU2237443382.USD","AZN","LU1829250122.USD","LU2236285917.USD","LU2237443549.SGD","AZNH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662835787","title":"AstraZeneca (AZN) Receives a Sell from Deutsche Bank","url":"https://stock-news.laohu8.com/highlight/detail?id=2662835787","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662835787?lang=en_us&edition=fundamental","pubTime":"2026-08-25 16:36","pubTimestamp":1787646972,"startTime":"0","endTime":"0","summary":"In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Sell rating on AstraZeneca, with a price target of £115.00. Papadaki...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/astrazeneca-azn-receives-a-sell-from-deutsche-bank-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/astrazeneca-azn-receives-a-sell-from-deutsche-bank-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4566","LU2417539215.USD","AZN","LU0889565916.HKD","LU2237443382.USD","LU0320765992.SGD","BK4007","BK4568","IE00B3T34201.USD","LU0128525929.USD","LU1829250122.USD","LU2237443622.USD","AZNH","LU2237443978.SGD","LU2456880835.USD","LU2237443465.HKD","BK4585","LU0432979614.USD","LU1267930573.SGD","LU2236285917.USD","LU2089984988.USD","LU0289739699.SGD","LU0058720904.USD","LU0708994859.HKD","LU2468319806.SGD","BK4588","BK4552","LU0109394709.USD","LU0310800379.SGD","LU2462157665.USD","BK4118","LU2237443895.HKD","LU2237443549.SGD","DB","LU0029864427.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662378470","title":"Astrazeneca Prices $2.97 Billion Eurobond Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2662378470","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662378470?lang=en_us&edition=fundamental","pubTime":"2026-08-25 16:12","pubTimestamp":1787645532,"startTime":"0","endTime":"0","summary":"Astrazeneca  has priced four tranches of Eurobonds totalling 2.55 billion euros , the company said Tuesday.The offering is expected to close on Sept. 1.The offering consisted of 700 million euros of fixed-rate notes with a coupon of 3.402% maturing in 2030; 600 million euros of fixed-rate notes with a coupon of 3.652% maturing in 2032; 500 million euros of fixed-rate notes with a coupon of 3.923% maturing in 2035; and750 million euros of fixed-rate notes with a coupon of 4.169% maturing in 2038, the company said.The company plans to use the net proceeds of the offering for general corporate purposes, it said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2237443465.HKD","LU2237443895.HKD","IE00B3T34201.USD","LU2237443549.SGD","BK4568","LU2237443382.USD","LU1267930573.SGD","LU2236285917.USD","LU2237443978.SGD","LU2468319806.SGD","AZNH","LU2417539215.USD","LU0320765992.SGD","LU2089984988.USD","LU0058720904.USD","BK4007","LU0109394709.USD","LU2456880835.USD","LU0708994859.HKD","LU0029864427.USD","AZN","LU2462157665.USD","LU0128525929.USD","LU0289739699.SGD","LU0889565916.HKD","LU0432979614.USD","LU0310800379.SGD","BK4585","BK4588","LU2237443622.USD","LU1829250122.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662270799","title":"AstraZeneca’s AZD4144 Interaction Study Adds Quiet Support to AZN’s Pipeline Story","url":"https://stock-news.laohu8.com/highlight/detail?id=2662270799","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662270799?lang=en_us&edition=fundamental","pubTime":"2026-08-25 00:30","pubTimestamp":1787589051,"startTime":"0","endTime":"0","summary":"AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. AstraZeneca plc (AZN) is running a Phase 1 study called “An Open-lab...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/astrazenecas-azd4144-interaction-study-adds-quiet-support-to-azns-pipeline-story?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/astrazenecas-azd4144-interaction-study-adds-quiet-support-to-azns-pipeline-story?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2237443382.USD","LU2236285917.USD","LU0708994859.HKD","LU1829250122.USD","LU2468319806.SGD","LU0058720904.USD","AZN","LU0889565916.HKD","LU0128525929.USD","BK4588","LU2237443549.SGD","LU0310800379.SGD","AZNH","LU0289739699.SGD","LU0109394709.USD","LU2237443465.HKD","LU1267930573.SGD","BK4568","LU0320765992.SGD","IE00B3T34201.USD","LU2089984988.USD","BK4007","LU2417539215.USD","LU2237443622.USD","LU2237443978.SGD","LU0432979614.USD","LU2462157665.USD","BK4585","LU0029864427.USD","LU2456880835.USD","LU2237443895.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661914172","title":"AstraZeneca Rallies Friday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2661914172","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661914172?lang=en_us&edition=fundamental","pubTime":"2026-08-22 00:08","pubTimestamp":1787328480,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of AstraZeneca PLC  advanced 1.26% to GBP122.40 Friday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index  rising 0.64% to 10,816.56.AstraZeneca PLC closed 22.20% below its 52-week high of GBP157.32, which the company reached on February 18th.Trading volume totaled 1.8 million, compared to the 50-day average of 3.3 million.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128525929.USD","LU2462157665.USD","LU0310800379.SGD","LU0289739699.SGD","BK4585","LU0889565916.HKD","LU0058720904.USD","LU0432979614.USD","LU1267930573.SGD","LU2456880835.USD","LU1829250122.USD","LU2468319806.SGD","LU0708994859.HKD","LU0109394709.USD","LU2417539215.USD","LU2237443978.SGD","BK4007","AZN","LU2236285917.USD","LU0029864427.USD","LU2237443895.HKD","LU2237443382.USD","LU2237443465.HKD","LU2237443549.SGD","LU2237443622.USD","AZNH","BK4588","LU2089984988.USD","BK4568","LU0320765992.SGD","IE00B3T34201.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661369612","title":"AstraZeneca’s SELENE 3 Trial Targets Extra Weight-Loss Upside for AZN Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2661369612","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661369612?lang=en_us&edition=fundamental","pubTime":"2026-08-21 00:30","pubTimestamp":1787243448,"startTime":"0","endTime":"0","summary":"AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. AstraZeneca plc (AZN) has launched SELENE 3, a large Phase III trial...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/astrazenecas-selene-3-trial-targets-extra-weight-loss-upside-for-azn-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/astrazenecas-selene-3-trial-targets-extra-weight-loss-upside-for-azn-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2468319806.SGD","BK4585","LU0029864427.USD","AZNH","IE00B3T34201.USD","LU2237443622.USD","LU0128525929.USD","LU2456880835.USD","LU0058720904.USD","AZN","LU2237443382.USD","LU2417539215.USD","ISBC","LU0889565916.HKD","LU2237443978.SGD","LU0432979614.USD","BK4211","LU1829250122.USD","LU2237443465.HKD","LU2089984988.USD","LU2462157665.USD","LU2237443549.SGD","BK4588","LU1267930573.SGD","LU0289739699.SGD","LU0109394709.USD","LU2236285917.USD","LU2237443895.HKD","BK4007","BK4568","LU0708994859.HKD","LU0310800379.SGD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107150558","title":"Dizhe Pharma Surpasses 500 Million Yuan in First-Half Revenue, Seals Global Exclusive Licensing Pact with AstraZeneca for Sunvozertinib","url":"https://stock-news.laohu8.com/highlight/detail?id=1107150558","media":"Deep News","labels":["corporation","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107150558?lang=en_us&edition=fundamental","pubTime":"2026-08-20 21:04","pubTimestamp":1787231098,"startTime":"0","endTime":"0","summary":"On August 20, Dizhe Pharma unveiled its 2026 interim financial report, disclosing total operating revenue of 523 million yuan for the reporting period, a 47% surge compared to the same period last...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","LU2237443549.SGD","LU2456880835.USD","IE00B3T34201.USD","LU1829250122.USD","LU1267930573.SGD","BK1161","09939","LU2089984988.USD","LU0289739699.SGD","AZNH","LU0708994859.HKD","BK4588","BK4007","LU2462157665.USD","BK4568","LU0128525929.USD","LU2468319806.SGD","LU0109394709.USD","159938","AZN","LU2237443382.USD","BK1515","LU2237443622.USD","LU2417539215.USD","BK4585","LU2237443978.SGD","LU0029864427.USD","LU2237443895.HKD","LU0432979614.USD","LU0889565916.HKD","LU2236285917.USD","LU0310800379.SGD","LU2237443465.HKD","BK1574","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105079363","title":"Third Indication Approved in China for AstraZeneca's Ultomiris","url":"https://stock-news.laohu8.com/highlight/detail?id=1105079363","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105079363?lang=en_us&edition=fundamental","pubTime":"2026-08-20 16:54","pubTimestamp":1787216081,"startTime":"0","endTime":"0","summary":"On August 20, the National Medical Products Administration (NMPA) website showed that AstraZeneca PLC (NASDAQ: AZN) has received approval for a new indication for its drug \"Ravulizumab\" in China,...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPOS","LU0109394709.USD","LU2462157665.USD","BK4007","BK4585","LU2417539215.USD","BK4588","LU0029864427.USD","LU0320765992.SGD","LU0889565916.HKD","IE00B3T34201.USD","LU0128525929.USD","LU2237443622.USD","LU0289739699.SGD","LU2237443978.SGD","LU0708994859.HKD","LU2089984988.USD","LU2237443895.HKD","LU0058720904.USD","LU1829250122.USD","LU2237443382.USD","LU2236285917.USD","AZN","BK4568","LU2468319806.SGD","LU0310800379.SGD","AZNH","LU0432979614.USD","LU1267930573.SGD","LU2237443549.SGD","LU2456880835.USD","LU2237443465.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660478118","title":"AstraZeneca PLC Stock (AZN) Moved Up by 3.40% on Aug 19: What Signal Does It Send?","url":"https://stock-news.laohu8.com/highlight/detail?id=2660478118","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660478118?lang=en_us&edition=fundamental","pubTime":"2026-08-20 03:16","pubTimestamp":1787167000,"startTime":"0","endTime":"0","summary":"• Positive oncology trial results drove AstraZeneca shares upward alongside bullish analyst commentary.\n• Fading merger rumors shifted investor focus back to the company's organic growth.\n• Annual revenue reached $58.74 billion with net profit at $10.22 billion.","market":"sg","thumbnail":"https://resource.tradingkey.com/uploads/20251024/AstraZeneca-000ba9f6d3d446b080935cd9fe1dade4.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20251024/AstraZeneca-000ba9f6d3d446b080935cd9fe1dade4.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262118853-market-movers-azn-20260819","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","LU2468319806.SGD","LU0889565916.HKD","AZN","LU1267930573.SGD","LU2237443382.USD","LU2417539215.USD","AZNH","LU0708994859.HKD","LU2236285917.USD","BK4585","BK4007","LU0029864427.USD","LU2237443895.HKD","LU2237443978.SGD","LU2237443465.HKD","BK4588","LU2462157665.USD","LU0310800379.SGD","LU2237443622.USD","LU2456880835.USD","LU2237443549.SGD","LU0432979614.USD","LU2089984988.USD","LU1829250122.USD","LU0058720904.USD","IE00B3T34201.USD","BK4568","LU0109394709.USD","LU0128525929.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660449294","title":"The Key to Pharma M&A: Never Shopping Hungry - Heard on the Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2660449294","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660449294?lang=en_us&edition=fundamental","pubTime":"2026-08-19 17:30","pubTimestamp":1787131800,"startTime":"0","endTime":"0","summary":"Everyone who has walked into a grocery store hungry knows how quickly discipline can evaporate. Everything looks like an immediate necessity.The same psychological trap plays out in Big Pharma boardro","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2491049909.HKD","SG9999015978.USD","LU2357305700.SGD","LU0786609619.USD","IE00BJJMRX11.SGD","LU1201861249.SGD","LU1989771016.USD","LU2491050154.USD","LU0267386448.USD","LU1670711123.USD","LU2552382215.SGD","LU2265009873.SGD","LU0203202063.USD","LU0965508806.USD","LU2125909247.SGD","SG9999018857.SGD","IE00BJJMRZ35.SGD","SGXZ51526630.SGD","LU1670710661.SGD","LU2237443549.SGD","LU2471134879.HKD","LU0345770308.USD","LU2125154778.USD","LU0345770993.USD","LU1934455863.HKD","LU1267930573.SGD","LU0225771236.USD","SG9999014898.SGD","LU0109394709.USD","IE0009355771.USD","BK4007","IE00B1BXHZ80.USD","LU2111349929.HKD","LU0130517989.USD","LU1929549753.HKD","LU0320765489.SGD","GB00BDT5M118.USD","LU1720051108.HKD","IE0002141913.USD","BK4581","LU2112291526.USD","SG9999015341.SGD","LU2023250330.USD","LU2271345857.HKD","LU2461242641.AUD","LU0985481810.HKD","LU0320765059.SGD","LU1829250122.USD","LU0820561909.HKD","LU0417517546.SGD","LU0820561818.USD","LU0061475181.USD","LU2471134796.USD","LU2360032135.SGD","LU0859254822.USD","LU0353189680.USD","LU0310800379.SGD","LU0466842654.USD","LU1989772923.USD","BK4533","LU2211815571.USD","LU0114720955.EUR","LU0225283273.USD","LU2361045086.USD","BK4585","LU0203347892.USD","RXL","LU1116320901.HKD","LU2213496289.HKD","IE00B4JS1V06.HKD","SG9999013999.USD","LU0174119429.USD","LU2602419157.SGD","LU0477156953.USD","LU1232071149.USD","LU0070302665.USD","SG9999001440.SGD","LU0128525929.USD","LU0320765646.SGD","LU1983299246.USD","LU0306806265.USD","LU2168564149.EUR","LU0109391861.USD","LU2756315318.SGD","IE00BLSP4239.USD","LU0889565916.HKD","LU1720051017.SGD","LU0098860793.USD","LU0096364046.USD","LU0708994859.HKD","LU2237438978.USD","BMY","LU1670710588.SGD","LU2125909593.SGD","LU2242652126.USD","LU2237443978.SGD","IE00B2B36J28.USD","LU1585245621.USD","LU0256863902.USD","LU2417539215.USD","LU0882574139.USD","LU0882574055.USD","VHT","LU1934455277.USD","LU0133085943.USD","LU0265550359.USD","BK4588","LU0964807845.USD","IE00BN8TJ469.HKD","BK4532","IE00BJLML261.HKD","LU1291159041.SGD","LU1116320737.USD","LU2750360997.AUD","IE00B3T34201.USD","SG9999014880.SGD","LU1804176565.USD","LU2236285917.USD","LU2237443465.HKD","LU1162221912.USD","LU1093756168.USD","LU0432979614.USD","SGXZ81514606.USD","IE00BWXC8680.SGD","LU1093756325.SGD","LU0787776722.HKD","IE0001KFT4U8.USD","LU2237443895.HKD","LU0097036916.USD","LU0006306889.USD","LU2360106947.USD","IE00BKDWB100.SGD","LLYX","LU2108987350.USD","IE000M9KFDE8.USD","IE00BKPKM429.USD","LU1430594728.SGD","PAWZ","LU1261432733.SGD","LU0861579265.USD","LU2023250843.SGD","IE00BBT3K403.USD","LU1069344957.HKD","WDNA","LU1699723380.USD","LU0471298694.HKD","LU0237698245.USD","LU1571399168.USD","SG9999001176.SGD","LU0124676726.USD","LU1917777945.USD","LU1934455194.USD","LU1941712264.USD","XLV","LU1069347547.HKD","LU2433249047.HKD","LU0198837287.USD","LU0823434740.USD","LU2746668461.USD","SG9999014914.USD","LU1868837300.USD","LU0868494708.USD","LU0306807586.USD","LU0289739699.SGD","LU1868836914.USD","LU0029864427.USD","IE0004445015.USD","LU1032466523.USD","IE00BJJMRY28.SGD","IE00B1XK9C88.USD","BK4534","LU2237443622.USD","LU0942090050.USD","MEDX","LU0106261372.USD","LU0321505439.SGD","LU2023251221.USD","AGNG","LU0265550946.USD","SG9999002232.USD","LU2596442595.SGD","CURE","LU1267930730.SGD","LU2089984988.USD","LU1023059063.AUD","LLY","LU0689472784.USD","LU1037948541.HKD","BK4578","LU2089283258.USD","LU0708995401.HKD","LU0210536198.USD","LU1037948897.HKD","CANC","LU2361044949.HKD","LU2756315664.SGD","HRTS","LU2456880835.USD","LU1988902786.USD","SG9999018865.SGD","AZN","LU0158827781.USD","LU0456855351.SGD","LU1718418525.SGD","LU1814569148.SGD","LU2028103732.USD","NVS","LU2063271972.USD","LU1670711040.USD","LU0868494617.USD","MHIP","LU0094547139.USD","IE00BFSS7M15.SGD","LU1066051225.USD","LU1989772840.SGD","LU1623119135.USD","LU2462157665.USD","LU2462591350.SGD","LU0122379950.USD","LU0234572021.USD","LU1127390331.HKD","LU2106854487.HKD","BMED","AZNH","LU0058720904.USD","LU1035773651.USD","LU1074936037.SGD","LU0471298777.SGD","SG9999014542.SGD","SG9999014567.USD","LU1979441026.SGD","LU2264538146.SGD","LU2168564222.USD","SG9999014575.USD","LLYZ","SGXZ57979304.SGD","IYH","LU2552382058.USD","LU2471134952.CNY","MEDI","LU2087625088.SGD","LU1868837136.USD","JDOC","FHLC","IE00BLSP4452.SGD","LU0683600562.USD","LU1974910355.USD","LU0130102774.USD","LU0823434583.USD","LU1323610961.USD","LU0354030511.USD","LU0823416689.USD","PPH","LU1712237335.SGD","LU0354030438.USD","TRUH","ELIL","LU1057294990.SGD","SG9999015358.SGD","LU1066053197.SGD","LU0211331839.USD","LU1941712348.USD","IE00BK4W5M84.HKD","LU0256863811.USD","IE0005OL40V9.USD","LU0225284248.USD","LU1061106388.HKD","LU2168564065.EUR","LU0965509283.SGD","LU1064131342.USD","FTXH","LU2168564495.EUR","LU1691799644.USD","LU1551013342.USD","LU1551013425.SGD","LU0385154629.USD","IE00BN29S564.USD","LU0980610538.SGD","LU2896262040.SGD","LU1923622614.USD","LU0672654240.SGD","LU0203201768.USD","LU1548497426.USD","LU0965509101.SGD","IE00BFSS8Q28.SGD","ILDR","LU0208291251.USD","TMED","LU2324357040.USD","BK4516","LU1366192091.USD","LU2746668974.SGD","IXJ","LU0353189763.USD","GDOC","BK4550","LU2552382132.HKD","IE00BK4W5L77.USD","LU0079474960.USD","LU2125154935.USD","IE00B775H168.HKD","LU2468319806.SGD","LU1868836757.USD","SG9999001176.USD","LU0820562030.AUD","BK4559","IE00BSNM7G36.USD","SGXZ31699556.SGD","LU0158827948.USD","SG9999015945.SGD","LU2237443382.USD","LU2168563687.JPY","MRK","LU1145028129.USD","IE00B4R5TH58.HKD","THNR","LU1629891620.HKD","LU1280957306.USD","SG9999017495.SGD","LU0648001328.SGD","LU0323591593.USD","IE00BFXG1179.USD","LU0320765992.SGD","LU0965509010.AUD","LU0238689110.USD","LU1035775433.USD","IHE","LU2491050071.SGD","LU0943347566.SGD","SG9999014559.SGD","LU0689626769.HKD","IE00B7KXQ091.USD","LU0316494557.USD","BK4599","LU1066051498.USD","PJP","IE00BFTCPJ56.SGD","LLII","LU2023250504.SGD","LU2089284900.SGD","SG9999015986.USD","LU1883839398.USD","LU2357627491.SGD","SG9999002224.SGD","LU0321505868.SGD","LU1066051811.HKD","LU0640476718.USD","ELIS","IE0004445239.USD","LU0203345920.USD","IE00BJT1NW94.SGD","OZEM","LU2242646821.SGD","SG9999015952.SGD","LU2750360641.GBP","LU2471134523.USD","LU1868836591.USD","BK4568","LU0266013472.USD","SG9999014906.USD","LU0985320562.USD","LU2361044865.SGD","LU2133065610.SGD","SGXZ99366536.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}